Heme Oxygenase 1 Is Differentially Involved in Blood Flow–Dependent Arterial Remodeling

Hypertension - Tập 58 Số 2 - Trang 225-231 - 2011
Mohamed Lamine Freidja1,2,3, Bertrand Toutain1,2,3, Antoine Caillon1,2,3, Valérie Desquiret‐Dumas2,3, Diane K. Lambert1,2,3, Laurent Loufrani1,2,3, Vincent Procaccio1,2,3, Daniel Henrion1,2,3
1CHU d'Angers, (V.D., D.L., V.P.), Angers France
2From the Centre National de la Recherche Scientifique UMR 6214 (L.L., D.H.), Angers, France; INSERM U771 (D.H.), Angers, France; CHU d'Angers, (V.D., D.L., V.P.), Angers France; Université d'Angers (M.L.F., B.T., A.C., V.P.), Angers, France.
3INSERM U771 (D.H.), Angers, France

Tóm tắt

Heme oxygenase 1 is induced by hemodynamic forces in vascular smooth muscle and endothelial cells. We investigated the involvement of heme oxygenase 1 in flow (shear stress)-dependent remodeling. Two or 14 days after ligation of mesenteric resistance arteries, vessels were isolated. In rats, at 14 days, diameter increased by 23% in high-flow arteries and decreased by 22% in low-flow arteries compared with normal flow vessels. Heme oxygenase activity inhibition using Tin-protoporphyrin abolished diameter enlargement in high-flow arteries and accentuated arterial narrowing in low-flow arteries (32% diameter decrease versus 22% in control). Two days after ligation, heme oxygenase 1 expression increased in high-flow and low-flow vessels, in association with a reduced mitochondrial aconitase activity (marker of oxidative stress) in high-flow arteries only. Inhibition of macrophage infiltration (clodronate) decreased heme oxygenase 1 induction in low-flow but not in high-flow arteries. Similarly, inhibition of NADPH oxidase activity (apocynin) decreased heme oxygenase 1 induction in low-flow but not high-flow arteries. However, dihydroethidium staining was higher in high-flow and low-flow compared with normal flow arteries. In arteries cannulated in an arteriograph, heme oxygenase 1 mRNA increased in a flow-dependent manner and was abolished by N G -nitro- l -arginine methyl ester, catalase, or mitochondrial electron transport chain inhibition. Furthermore, heme oxygenase 1 induction using cobalt-protoporphyrin restored altered high-flow remodeling in endothelial NO synthase knockout mice. Thus, in high-flow remodeling, heme oxygenase 1 induction depends on shear stress–generated NO and mitochondria-derived hydrogen peroxide. In low-flow remodeling, heme oxygenase 1 induction requires macrophage infiltration and is mediated by NADPH oxidase–derived superoxide.

Từ khóa


Tài liệu tham khảo

10.1089/ars.2005.7.1761

10.1073/pnas.86.1.99

10.1016/j.freeradbiomed.2006.10.043

10.1089/ars.2004.6.924

10.1089/ars.2005.7.1674

10.1126/stke.2302004re6

10.1126/science.3029864

10.1146/annurev.pharmtox.37.1.517

10.1161/01.atv.0000254684.80662.44

10.1161/01.ATV.16.10.1256

10.3109/10739689609148284

10.1152/ajpheart.1997.273.4.H1699

10.1172/JCI119569

10.1074/jbc.M203161200

10.1093/cvr/cvn050

10.1080/10739680902816301

Biewenga J, van der Ende MB, Krist LF, Borst A, Ghufron M, van Rooijen N. Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant. Cell Tissue Res. 1995;280:189–196.

10.1016/0022-1759(94)90012-4

10.1161/hypertensionaha.108.127456

10.1161/01.atv.0000032652.24932.1a

10.1038/sj.bjp.0703371

10.1161/hypertensionaha.109.140236

10.1093/cvr/cvm055

10.1038/ng1097-215

10.1016/j.biochi.2008.05.003

10.1038/hr.2010.83

10.1161/01.RES.0000047505.11002.81

10.1073/pnas.84.8.2464

10.1093/cvr/cvp411

10.1161/hypertensionaha.107.088716

10.1161/01.res.0000181759.63239.21

10.1016/S1357-2725(97)00061-7

Buschmann I, Schaper W. Arteriogenesis versus angiogenesis: two mechanisms of vessel growth. News Physiol Sci. 1999;14:121–125.

10.1159/000189797

10.1152/ajpregu.00361.2003

10.1124/jpet.108.145557

10.1016/j.bbrc.2004.11.083

10.1093/cvr/cvn334

10.1152/ajpheart.00966.2006

10.1172/JCI24403

10.1016/j.expneurol.2010.03.032